Placebo oil (MCT oil)
Preclinical
Placebo oil (MCT oil) is one of 9 therapeutic programs targeting Major Depressive Disorder (MDD). It is currently in Preclinical.
1
Indications
1
Total Trials
1
Active Trials
8
Competitors
Pipeline
Status by Indication[2][1]
Indication
Competition
Competitive Landscape
8 competitors in Major Depressive Disorder (MDD)
#DrugCompanyPhaseTrials
1Ketalar
Boehringer IngelheimApproved
CYB003
CCybin IRL Limited
Phase 3
Thiamine
UUniversiti Kebangsaan Malaysia Medical Centre
Phase 2
PET Scan With VAT
SStony Brook University
Phase 3
Celebrex
PPhiladelphia Eye Associates
Preclinical
SPT-300
SSeaport Therapeutics
Phase 2
DT-101
DDraig Therapeutics Ltd
Phase 2
Ketamine Only
UUniversity of Pennsylvania
Phase 1
Placebo oil (MCT oil)
UUniversidade do Sul de Santa Catarina
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]Open Targets Platform — Drug–disease associations for Placebo oil (MCT oil). EMBL-EBI & Wellcome Sanger Institute.
- [3]
Details
Drug Info
Quick Facts
- Highest Phase
- Preclinical[1]